EUVIMEDEUVIMED entdecken
Crossref

Rational Design and Screening of Chemically Modified Anti-SARS-CoV-2 siRNA

Zihui Cheng iD, Ying Cai iD, Enhua Zhang iD, Yong Cheng, Yizhe Li, Xiaojuan Zhang, Guochun Liang, Mengying Hou, Can Wang, Tianwen Hu, Guanghui Tian, Yuanchao Xie iD und 2 weitere

ACS Infectious Diseases · 08.05.2026 · 12 (5) · 1727-1738

DOI: 10.1021/acsinfecdis.6c00095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 27.04.2026. Verfasst von Zihui Cheng und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201210, China. Hauptthemen laut MEDLINE: RNA, Small Interfering, SARS-CoV-2, Antiviral Agents. Die Arbeit nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Small InterferingSARS-CoV-2Antiviral AgentsHumansRNA InterferenceAnimalsRNA-Dependent RNA PolymeraseCOVID-19Vero Cells

Stichwörter der Autor:innen

RdRpSARS-CoV-2asymmetric modificationmodification patternsiRNA

Substanzen

RNA, Small InterferingRNA-Dependent RNA PolymeraseAntiviral Agents

Autor:innen und Institutionen

  • State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201210, China.
  • University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, PR China.
  • Vigonvita Shanghai Co., Ltd., Shanghai 201210, China.
  • School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China.
  • College of Pharmacy, Xinjiang Medical University, Urumqi 830054, PR China.
  • Lingang Laboratory, Shanghai 200031, People's Republic of China.

ORCID-Profile: Zihui Cheng, Ying Cai, Enhua Zhang, Yuanchao Xie, Wei Zheng, Jingshan Shen

Zitieren

APA

Cheng, Z., Cai, Y., Zhang, E., Cheng, Y., Li, Y., Zhang, X., Liang, G., Hou, M., Wang, C., Hu, T., Tian, G., Xie, Y., Zheng, W., & Shen, J. (2026). Rational Design and Screening of Chemically Modified Anti-SARS-CoV-2 siRNA. ACS Infectious Diseases, 12(5), 1727-1738. https://doi.org/10.1021/acsinfecdis.6c00095

Vancouver

Cheng Z, Cai Y, Zhang E, Cheng Y, Li Y, Zhang X, et al. Rational Design and Screening of Chemically Modified Anti-SARS-CoV-2 siRNA. ACS Infectious Diseases. 2026;12(5):1727-1738. doi:10.1021/acsinfecdis.6c00095

BibTeX
@article{Cheng2026,
  author = {Cheng, Zihui and Cai, Ying and Zhang, Enhua and Cheng, Yong and Li, Yizhe and Zhang, Xiaojuan and Liang, Guochun and Hou, Mengying and Wang, Can and Hu, Tianwen and Tian, Guanghui and Xie, Yuanchao and Zheng, Wei and Shen, Jingshan},
  title = {Rational Design and Screening of Chemically Modified Anti-SARS-CoV-2 siRNA},
  journal = {ACS Infectious Diseases},
  year = {2026},
  volume = {12},
  number = {5},
  pages = {1727--1738},
  doi = {10.1021/acsinfecdis.6c00095}
}
Kostenlos starten →